Valproate Safety Programme · Loftus

Valproate Safety Programme in Loftus.

Pharmacist-owned valproate safety programme — annual PPP review, ARAF documentation and prescribing change support, with audit-ready evidence. Delivered to Loftus PCNs and GP practices from the BCS Halifax (West Yorkshire) hub, with paired cover from our Chiswick (West London) hub — the only UK dual-hub clinical pharmacy model.

Loftus · local context

Loftus PCNs sit within NHS North East and North Cumbria ICB.

Loftus PCNs cover former industrial communities with significant CVD, COPD and care home demand — pharmacist programmes lean on high-risk drug monitoring and LTC reviews.

What you get

What valproate safety in Loftus actually looks like.

  • Annual Pregnancy Prevention Programme review
  • ARAF documentation
  • Contraception counselling and signposting
  • Prescribing change support
  • Audit-ready evidence pack

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every valproate safety placement in Loftus is mobilised from one of our two clinical hubs — Halifax (West Yorkshire) as the lead and Chiswick (West London) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Halifax (West Yorkshire) hub
  • Paired cover from BCS Chiswick (West London)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

Loftus · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Loftus
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Loftus PCNs choose BCS for valproate safety.

Solo recruitment for valproate safety in Loftus leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Halifax (West Yorkshire)/Chiswick (West London) dual-hub.

Frequently asked questions — Valproate Safety Programme in Loftus.

Does this meet the MHRA valproate requirements?+

Yes — the BCS valproate programme is designed against the current MHRA Pregnancy Prevention Programme requirements.

Does BCS already deliver valproate safety in Loftus?+

BCS supports PCNs across North East from our Halifax (West Yorkshire) hub with paired cover from Chiswick (West London), and is actively delivering or available to mobilise valproate safety in Loftus. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise valproate safety in Loftus?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call